Your browser doesn't support javascript.
loading
Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes.
Esin, Ece; Oksuzoglu, B; Bilici, A; Cicin, I; Kostek, O; Kaplan, M A; Aksoy, S; Aktas, B Y; Ozdemir, O; Alacacioglu, A; Cabuk, D; Sumbul, A T; Sakin, A; Paydas, S; Yetisir, E; Er, O; Korkmaz, T; Yildirim, N; Sakalar, T; Demir, H; Artac, M; Karaagac, M; Harputluoglu, H; Bilen, E; Erdur, E; Degirmencioglu, S; Aliyev, A; Cil, T; Olgun, P; Basaran, G; Gumusay, O; Demir, A; Tanrikulu, E; Yumuk, P F; Imamoglu, Inanc; Oyan, B; Cetin, B; Haksoyler, V; Karadurmus, N; Erturk, I; Evrensel, T; Yilmaz, H; Beypinar, I; Kocer, M; Pilanci, K N; Seker, M; Urun, Y; Yildirim, N; Eren, T; Demirci, U.
Afiliación
  • Esin E; Department of Medical Oncology, Dr. A. Y. Ankara Oncology Education and Research Hospital, University of Health Sciences, Yenimahalle, Ankara, Turkey. Dr.eceesin@gmail.com.
  • Oksuzoglu B; Department of Medical Oncology, Dr. A. Y. Ankara Oncology Education and Research Hospital, University of Health Sciences, Yenimahalle, Ankara, Turkey.
  • Bilici A; Departmant of Medical Oncology, Medipol University International Health Center, Istanbul, Turkey.
  • Cicin I; Department of Medical Oncology, Trakya University, Edirne, Turkey.
  • Kostek O; Department of Medical Oncology, Trakya University, Edirne, Turkey.
  • Kaplan MA; Department of Medical Oncology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey.
  • Aksoy S; Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Aktas BY; Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Ozdemir O; Department of Medical Oncology, Ataturk Education and Research Hospital, Izmir K.C. University, Izmir, Turkey.
  • Alacacioglu A; Department of Medical Oncology, Ataturk Education and Research Hospital, Izmir K.C. University, Izmir, Turkey.
  • Cabuk D; Department of Medical Oncology, Faculty of Medicine, Kocaeli University, Izmit, Turkey.
  • Sumbul AT; Department of Medical Oncology, Baskent University Adana Hospital, Adana, Turkey.
  • Sakin A; Department of Medical Oncology, Istanbul Okmeydani Education and Research Hospital, Istanbul, Turkey.
  • Paydas S; Department of Medical Oncology, Faculty of Medicine, Cukurova University, Adana, Turkey.
  • Yetisir E; Department of Medical Oncology, Faculty of Medicine, Cukurova University, Adana, Turkey.
  • Er O; Department of Medical Oncology, Acibadem Maslak Hospital, Acibadem MAA University, Istanbul, Turkey.
  • Korkmaz T; Department of Medical Oncology, Acibadem Altunizade Hospital, Acibadem MAA University, Istanbul, Turkey.
  • Yildirim N; Department of Medical Oncology, Dr. Ersin Arslan Training and Research Hospital, Gaziantep, Turkey.
  • Sakalar T; Department of Medical Oncology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
  • Demir H; Department of Medical Oncology, Kayseri Education and Research Hospital, University of Health Sciences, Kayseri, Turkey.
  • Artac M; Department of Medical Oncology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey.
  • Karaagac M; Department of Medical Oncology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey.
  • Harputluoglu H; Department of Medical Oncology, Turgut Ozal Medical Center, Inonu University, Malatya, Turkey.
  • Bilen E; Department of Medical Oncology, Turgut Ozal Medical Center, Inonu University, Malatya, Turkey.
  • Erdur E; Department of Medical Oncology, Dr. A. Y. Ankara Oncology Education and Research Hospital, University of Health Sciences, Yenimahalle, Ankara, Turkey.
  • Degirmencioglu S; Department of Medical Oncology, Faculty of Medicine, Pamukkale University, Denizli, Turkey.
  • Aliyev A; Department of Medical Oncology, Faculty of Medicine, Bezmialem University, Istanbul, Turkey.
  • Cil T; Department of Medical Oncology, Adana City Hospital, University of Health Sciences, Adana, Turkey.
  • Olgun P; Department of Medical Oncology, Adana City Hospital, University of Health Sciences, Adana, Turkey.
  • Basaran G; Department of Medical Oncology, Acibadem Maslak Hospital, Acibadem MAA University, Istanbul, Turkey.
  • Gumusay O; Department of Medical Oncology, Faculty of Medicine, Gaziosmanpasa University, Tokat, Turkey.
  • Demir A; Department of Medical Oncology, Istanbul Okmeydani Education and Research Hospital, University of Health Sciences, Istanbul, Turkey.
  • Tanrikulu E; Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey.
  • Yumuk PF; Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey.
  • Imamoglu I; Department of Medical Oncology, Ankara Diskapi Education and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Oyan B; Department of Medical Oncology, Acibadem Altunizade Hospital, Acibadem MAA University, Istanbul, Turkey.
  • Cetin B; Department of Medical Oncology, Faculty of Medicine, RTE University, Rize, Turkey.
  • Haksoyler V; Department of Medical Oncology, Diyarbakir G.Y. Education and Research Hospital, University of Health Sciences, Diyarbakir, Turkey.
  • Karadurmus N; Department of Medical Oncology, Gulhane Education and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Erturk I; Department of Medical Oncology, Gulhane Education and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Evrensel T; Department of Medical Oncology, Faculty of Medicine, Uludag University, Bursa, Turkey.
  • Yilmaz H; Department of Medical Oncology, Faculty of Medicine, Uludag University, Bursa, Turkey.
  • Beypinar I; Department of Medical Oncology, Faculty of Medicine, Afyon Kocatepe University, Afyon, Turkey.
  • Kocer M; Department of Medical Oncology, Faculty of Medicine, Isparta S.D University, Isparta, Turkey.
  • Pilanci KN; Department of Medical Oncology, Haseki Education and Research Hospital, University of Health Sciences, Istanbul, Turkey.
  • Seker M; Department of Medical Oncology, Ankara Bayindir Hospital, Ankara, Turkey.
  • Urun Y; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Yildirim N; Department of Medical Oncology, Numune Education and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Eren T; Department of Medical Oncology, Numune Education and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Demirci U; Department of Medical Oncology, Dr. A. Y. Ankara Oncology Education and Research Hospital, University of Health Sciences, Yenimahalle, Ankara, Turkey.
Cancer Chemother Pharmacol ; 83(1): 131-143, 2019 01.
Article en En | MEDLINE | ID: mdl-30377778
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pautas de la Práctica en Medicina / Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Lobular / Carcinoma Ductal de Mama Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Turquía
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pautas de la Práctica en Medicina / Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Lobular / Carcinoma Ductal de Mama Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Turquía